IKNA
Income statement / Annual
Last year (2024), Ikena Oncology, Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2024, Ikena Oncology, Inc.'s net income was -$49.23 M.
See Ikena Oncology, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$0.00 |
$9.16 M |
$15.62 M |
$30.99 M |
$9.19 M |
$13.75 M |
$990.00 K |
| Cost of Revenue |
$490.00 K
|
$1.02 M
|
$64.32 M
|
$47.11 M
|
$44.85 M
|
$24.94 M
|
$38.99 M
|
| Gross Profit |
-$490.00 K
|
$8.14 M
|
$13.58 M
|
-$16.12 M
|
-$35.65 M
|
-$11.19 M
|
-$38.00 M
|
| Gross Profit Ratio |
0
|
0.89
|
0.87
|
-0.52
|
-3.88
|
-0.81
|
-38.38
|
| Research and Development Expenses |
$30.39 M
|
$59.65 M
|
$64.32 M
|
$47.11 M
|
$44.85 M
|
$24.94 M
|
$38.56 M
|
| General & Administrative Expenses |
$23.68 M
|
$24.93 M
|
$22.20 M
|
$18.02 M
|
$8.87 M
|
$7.31 M
|
$2.90 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$23.68 M
|
$24.93 M
|
$22.20 M
|
$18.02 M
|
$8.87 M
|
$7.31 M
|
$2.90 M
|
| Other Expenses |
$0.00
|
-$1.02 M
|
-$2.03 M
|
-$47.11 M
|
-$44.85 M
|
$0.00
|
$0.00
|
| Operating Expenses |
$54.06 M
|
$83.56 M
|
$84.49 M
|
$18.02 M
|
$8.87 M
|
$32.25 M
|
$41.46 M
|
| Cost And Expenses |
$54.55 M
|
$84.58 M
|
$86.52 M
|
$65.12 M
|
$53.71 M
|
$32.25 M
|
$41.88 M
|
| Interest Income |
$7.37 M
|
$7.11 M
|
$2.15 M
|
$23.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$490.00 K
|
$1.02 M
|
$751.00 K
|
$544.00 K
|
$300.00 K
|
$122.00 K
|
$422.00 K
|
| EBITDA |
-$48.59 M |
-$74.40 M |
-$70.15 M |
-$33.59 M |
-$44.22 M |
-$18.37 M |
-$40.44 M |
| EBITDA Ratio |
0
|
-8.12
|
-4.49
|
-1.08
|
-4.81
|
-1.34
|
-40.85
|
| Operating Income Ratio |
0
|
-8.23
|
-4.54
|
-1.1
|
-4.84
|
-1.34
|
-41.31
|
| Total Other Income/Expenses Net |
$9.89 M
|
$7.09 M
|
$2.14 M
|
$23.00 K
|
$263.00 K
|
$1.68 M
|
$29.00 K
|
| Income Before Tax |
-$49.08 M
|
-$68.33 M
|
-$68.77 M
|
-$34.12 M
|
-$44.26 M
|
-$16.82 M
|
-$40.87 M
|
| Income Before Tax Ratio |
0
|
-7.46
|
-4.4
|
-1.1
|
-4.81
|
-1.22
|
-41.28
|
| Income Tax Expense |
$152.00 K
|
-$162.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$49.23 M
|
-$68.17 M
|
-$68.77 M
|
-$34.12 M
|
-$44.26 M
|
-$16.82 M
|
-$40.87 M
|
| Net Income Ratio |
0
|
-7.44
|
-4.4
|
-1.1
|
-4.81
|
-1.22
|
-41.28
|
| EPS |
-1.02 |
-1.63 |
-1.9 |
-0.95 |
-3.16 |
-0.47 |
-1.14 |
| EPS Diluted |
-1.02 |
-1.63 |
-1.9 |
-0.95 |
-3.16 |
-0.47 |
-1.14 |
| Weighted Average Shares Out |
$48.26 M
|
$41.74 M
|
$36.19 M
|
$35.98 M
|
$13.99 M
|
$35.85 M
|
$35.85 M
|
| Weighted Average Shares Out Diluted |
$48.26 M
|
$41.74 M
|
$36.19 M
|
$35.98 M
|
$13.99 M
|
$35.85 M
|
$35.85 M
|
| Link |
|
|
|
|
|
|
|
